Duke Infectious Disease Response Training Consortium (DIDRT)

杜克大学传染病应对培训联盟 (DIDRT)

基本信息

  • 批准号:
    9493482
  • 负责人:
  • 金额:
    $ 38.11万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2016
  • 资助国家:
    美国
  • 起止时间:
    2016-06-01 至 2019-05-31
  • 项目状态:
    已结题

项目摘要

Abstract Three epidemics (SARS in 2003, pandemic influenza in 2009, and Ebola in 2014) have tested our national preparedness for infectious disease emergencies, revealing both strengths and weaknesses. Identified weaknesses have highlighted the need for a national network of training consortium to ensure up-to-date, high quality, effective and efficient delivery of biosafety and infectious disease worker training. In response to the anthrax attacks of 2001, the NIAID/NIH funded construction of a network of Regional Biocontainment Laboratories (RBLs) with a mandate to support local and national responses to infectious disease emergencies. RBLs were strategically constructed at major academic medical centers and provide a nexus of training and outreach to healthcare and non-healthcare workers in their respective geographical catchment areas. The RBL at Duke University Medical Center was the first of the 12 RBLs to be fully commissioned in 2007 and has a comprehensive biosafety and infectious disease preparedness training program with an emphasis on CDC/NIAID Category A, B and C priority pathogens for multiple worker populations. In 2014 the RBL at Duke training team was activated to develop an Ebola treatment unit at Duke University Hospital, develop a care network for an Ebola suspect patient, and train custodial and healthcare workers. Consistent with the overall goal of the NIEHS worker training program we propose to use a subset of the NIAID-RBLs (Duke, Colorado State, U. Chicago, George. Mason U., and U. Louisville) to establish a multistate partnership to provide training in occupational settings that carry the potential for increased exposure to contaminated materials or infected individuals. We call this program Duke Infectious Disease Response Training (DIDRT). We will achieve this goal by accomplishing the following three Specific Aims: 1) Develop a multistate consortium of biosafety professionals within the NIAID RBL network to provide comprehensive infectious disease response training; 2) Train worker populations (first responders, custodial service, travel/Air transport, and healthcare/clinical lab) with important roles in infectious disease response; and 3) Evaluate the efficacy of preparedness training, incorporating the results in a continuous quality improvement cycle. The DIDRT consortium is uniquely qualified to achieve these three Aims. Our five-state consortium includes key leaders in the American Biological Safety Association (ABSA), including two former ABSA presidents (Hunt and Ellis), three former/current ABSA board members (Hunt, Alderman and Ellis), five Certified Biological Safety Professionals (Hunt, Frothingham Alderman, Ellis and Blair), and five Registered Biosafety Professionals (Burch, Blair, Zobel, Bivona, Quenee). Our RBL consortium members provide regular biosafety training (over 110,000 in the past five years) in formats ranging from short online modules to five-day courses. The collective knowledge of our team and th e strategic geographic locations of the DIDRT consortium members will enable the development of a truly nationwide program capable of meeting the needs of the NIEHS WTP.
摘要 三次流行病(2003年的SARS,2009年的大流行性流感和2014年的埃博拉病毒)已经考验了我们的国家 对传染病紧急情况的准备工作,揭示了优势和劣势。识别 这些弱点突出表明,需要建立一个全国性的培训联合会网络, 高质量、高效益和高效率地提供生物安全和传染病工作人员培训。响应于 2001年炭疽袭击后,NIAID/NIH资助建设了一个区域生物遏制网络, 授权支持地方和国家应对传染病的实验室(RBL) 突发事件RBL在主要的学术医疗中心战略性地构建,并提供以下联系: 在各自的地理范围内培训和推广医疗保健和非医疗保健工作者 地区杜克大学医学中心的RBL是年12个RBL中第一个完全投入使用的。 2007年,并有一个全面的生物安全和传染病准备培训计划, 强调CDC/NIAID A、B和C类优先病原体用于多个工人群体。2014年 杜克培训团队的RBL被激活,在杜克大学医院开发埃博拉治疗单元, 为埃博拉疑似患者建立一个护理网络,并培训监护和医疗工作者。一致 根据国家工业环境卫生服务体系工人培训计划的总体目标,我们建议使用国家工业环境卫生服务体系的一个子集--RBL (Duke美国科罗拉多州芝加哥,乔治。梅森大学,和联合路易斯维尔)建立多州伙伴关系 在可能增加接触受污染物质的职业环境中提供培训, 材料或受感染的个人。我们称之为杜克传染病应对培训(DIDRT)。 我们将通过实现以下三个具体目标来实现这一目标:1)发展一个多州 NIAID RBL网络内的生物安全专业人员联盟, 疾病应对培训; 2)培训工人群体(第一反应者,保管服务,旅行/航空运输, 和医疗保健/临床实验室)在传染病应对中发挥重要作用;以及3)评估 准备培训,将结果纳入持续质量改进周期。DIDRT 联合体是唯一有资格实现这三个目标。我们的五个国家联盟包括主要领导人在 美国生物安全协会(ABSA),包括两位前ABSA主席(亨特和埃利斯), 三名前/现任ABSA董事会成员(Hunt、Alderman和Ellis),五名认证生物安全 专业人员(Hunt、Frothingham Alderman、Ellis和Blair)和五名注册生物安全专业人员 (Burch,Blair,Zobel,Bivona,Quenee).我们的RBL联盟成员提供定期的生物安全培训(超过 过去五年中有110 000人),形式从简短的在线模块到五天的课程不等。集体 了解我们的团队和DIDRT联盟成员的战略地理位置, 制定一个真正的全国性计划,能够满足NIEHS WTP的需求。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Gregory D Sempowski其他文献

Gregory D Sempowski的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Gregory D Sempowski', 18)}}的其他基金

Core 2: Biocontainment and Immune Monitoring Core
核心2:生物防护和免疫监测核心
  • 批准号:
    10327521
  • 财政年份:
    2021
  • 资助金额:
    $ 38.11万
  • 项目类别:
Core 2: Biocontainment and Immune Monitoring Core
核心2:生物防护和免疫监测核心
  • 批准号:
    10842500
  • 财政年份:
    2021
  • 资助金额:
    $ 38.11万
  • 项目类别:
Core C: Thymic and peripheral Aspects of T cell Aging and Rejuvenation
核心 C:T 细胞衰老和再生的胸腺和外周方面
  • 批准号:
    10226918
  • 财政年份:
    2017
  • 资助金额:
    $ 38.11万
  • 项目类别:
BSL3 Flow Biomarker and Imaging
BSL3 流式生物标志物和成像
  • 批准号:
    8375869
  • 财政年份:
    2012
  • 资助金额:
    $ 38.11万
  • 项目类别:
BSL3 Flow Biomarker and Imaging
BSL3 流式生物标志物和成像
  • 批准号:
    8234182
  • 财政年份:
    2011
  • 资助金额:
    $ 38.11万
  • 项目类别:
Virology Core
病毒学核心
  • 批准号:
    9209230
  • 财政年份:
    2011
  • 资助金额:
    $ 38.11万
  • 项目类别:
Immune Monitoring
免疫监测
  • 批准号:
    8013124
  • 财政年份:
    2010
  • 资助金额:
    $ 38.11万
  • 项目类别:
Immunology Core
免疫学核心
  • 批准号:
    7764322
  • 财政年份:
    2009
  • 资助金额:
    $ 38.11万
  • 项目类别:
BSL3 Flow Biomarker and Imaging
BSL3 流式生物标志物和成像
  • 批准号:
    7671883
  • 财政年份:
    2009
  • 资助金额:
    $ 38.11万
  • 项目类别:
Mechanisms of Age Induced Thymic Atrophy
年龄引起胸腺萎缩的机制
  • 批准号:
    7647947
  • 财政年份:
    2005
  • 资助金额:
    $ 38.11万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 38.11万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 38.11万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 38.11万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 38.11万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 38.11万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 38.11万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 38.11万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 38.11万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 38.11万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 38.11万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了